Column Capital Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 91 shares of CRL stock, worth $15,284. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91
Previous 91
-0.0%
Holding current value
$15,284
Previous $19,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
708Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$855 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$685 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$366 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$304 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...